| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |